Mottola Frank

Track

Insider profile

Performance

Overall performance
2.7
Performance over holding periods
2.7
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 40% 68% 82%
Transactions
6 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Mottola Frank's trades of Supernus Pharmaceuticals, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-10 2026-03-09
S Sale
16,452 -43.1%
113.44
US$1,805,867 		16,452 -43.1% 113.44 US$1,805,867
2026-03-09 2026-03-09
PrS Proposed sale
61,975
129.44
US$1,411,436 		61,975 129.44 US$1,411,436
2025-12-22 2025-12-19
PlS Planned sale
27,241 +36.7%
82.73
US$676,405 		27,241 +36.7% 82.73 US$676,405
2025-12-22 2025-12-19
PlS Planned sale
5,000 -24.4%
50.22
US$251,100 		5,000 -24.4% 50.22 US$251,100
2025-12-19 2025-12-19
PrS Proposed sale
20,000
49.28
US$985,600 		20,000 49.28 US$985,600
2025-09-15 2025-09-12
S Sale
5,000 -24.4%
45.87
US$229,350 		5,000 -24.4% 45.87 US$229,350
2025-09-12 2025-09-12
PrS Proposed sale
5,000
45.87
US$229,338 		5,000 45.87 US$229,338
2025-08-27 2025-08-25
S Sale
14,000 -47.5%
44.51
US$623,140 		14,000 -47.5% 44.51 US$623,140
2025-08-25 2025-08-25
PrS Proposed sale
14,000
44.51
US$623,070 		14,000 44.51 US$623,070
2024-11-08 2024-11-07
S Sale
15,000 -64.7%
36.98
US$554,700 		15,000 -64.7% 36.98 US$554,700
2024-11-07 2024-11-07
PrS Proposed sale
15,000
36.98
US$554,692 		15,000 36.98 US$554,692
2023-11-16 2023-11-14
S Sale
1,110 -16.3%
28.13
US$31,224 		1,110 -16.3% 28.13 US$31,224
2023-11-14 2023-11-14
PrS Proposed sale
1,110
28.13
US$31,222 		1,110 28.13 US$31,222
2023-03-16 2023-03-14
S Sale
4,780 -50.2%
35.99
US$172,023 		4,780 -50.2% 35.99 US$172,023